Тип публикации: статья из журнала

Год издания: 2007

Идентификатор DOI: 10.1007/s10517-007-0416-0

Ключевые слова: Breast cancer, Etoposide, Laboratory mice and rats, animal experiment, animal model, article, breast carcinogenesis, cancer morphology, carcinogenic activity, CBA mouse, controlled study, experimental animal, female, histopathology, long term exposure, maximum tolerated dose, mouse, nonhuman, outbred strain, rat, single drug dose, species difference, toxicity testing, Wistar rat, Animals, Antineoplastic Agents, Breast Neoplasms, Injections, Intravenous, Mice, Rats, Rats, Wistar, Animalia, Mus, Rattus, Rattus norvegicus

Аннотация: Intravenous injection of antitumor drug etoposide in the maximum tolerated dose was followed by the development of breast cancer in 38.1% female Wistar rats and 6.7% female outbred mice. © Springer Science+Business Media, Inc. 2007.

Журнал: Bulletin of Experimental Biology and Medicine

Выпуск журнала: Vol. 144, Is. 5

Номера страниц: 725-727

• Fomina T.I. (Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences, Russian Federation)
• Perelmuter V.M. (Department of Pathoanatomy, Siberian State Medical University, Federal Agency for Health Care and Social Development, Russian Federation)
• Vtorushin S.V. (Department of Pathoanatomy, Siberian State Medical University, Federal Agency for Health Care and Social Development, Russian Federation)
• Zavjalova M.V. (Department of Pathoanatomy, Siberian State Medical University, Federal Agency for Health Care and Social Development, Russian Federation)
• Borovskaja T.G. (Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences, Russian Federation)
• Timina E.A. (Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences, Russian Federation)

• Scopus